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A report of the Keystone Symposium ‘Diverse roles for RNA
in gene regulation’, Breckenridge, USA, 8-15 January 2005.
The recent Keystone Symposium on the role of RNA in gene
regulation brought together a diverse and highly interactive
group of biochemists, geneticists, crystallographers, and
bioinformaticians to discuss the next frontier - how RNA reg-
ulates gene output at the transcriptional, translational, and
mRNA-stability level. Many new developments concerned the
biochemical mechanism of RNA interference (RNAi) and the
endogenous biological processes regulated by microRNAs
(miRNAs) and small interfering RNAs (siRNAs). There was,
however, also a strong appreciation of previously unanno-
tated RNA genes lurking in the genome and other novel
mechanisms by which RNA regulates gene expression. Partic-
ipants also heard about the fruition of efforts to exploit RNAi
for genome-wide functional studies and progress in the use of
the technology to develop human therapeutics. 
MicroRNAs come of age
The most hotly pursued class of non-coding RNA (ncRNA)
in recent years has been the miRNAs. Although research still
continues on miRNA discovery, the field has largely made
the transition to studying the endogenous biological func-
tions of miRNAs. In particular, speakers discussed computa-
tional or experimental approaches to identifying the specific
targets of miRNA regulation, as well as genetic approaches
to identifying mutant phenotypes associated with altered
miRNA activity.
David Bartel (Whitehead Institute, Massachusetts Institute
of Technology, Cambridge, USA) presented TargetScanS,
his group’s animal miRNA-target-finding algorithm. It pre-
dicts potential targets of miRNAs by searching for 3
untranslated region (UTR) sequences with highly and
specifically conserved Watson-Crick matches to positions
2-7 or 2-8 (the ‘seed’) of the query miRNA; increased confi-
dence is assigned to target sites with an adenosine at posi-
tion 1 of the miRNA interaction site. Bartel predicted that
at least one third of the genes in the human genome are
miRNA targets. Lee Lim (Rosetta Inpharmatics, Seattle,
USA) challenged the dogma that the main function of
animal miRNAs is to inhibit productive translation without
causing mRNA degradation. Lim found that miR-1 and
miR-124 in humans can indeed downregulate the tran-
script levels of approximately 100-200 genes via 3 UTR
seed matches. He speculated that mir-1 and  mir-124,
which are restricted to muscle/heart and the nervous
system, respectively, may have rather global effects on
gene expression that help maintain the identity of these
tissues.
Although many animal miRNA targets are regulated by
pairing of the miRNA to the 3 UTR of the target mRNA,
Tom Tuschl (Rockefeller University, New York, USA)
showed that several virus-encoded miRNAs are completely
antisense to viral mRNAs and are likely to be targeting them
for degradation. But miRNAs from any individual virus
exhibit little sequence similarity to miRNAs from animals,
plants, or other viruses, leading Tuschl to postulate that viral
miRNAs may have independently evolved multiple times. 
Jim Carrington (Oregon State University, Corvallis, USA)
added another twist to the story by describing an unexpectedly
complex regulatory pathway involving small RNAs in plants.
Certain plant miRNAs guide the cleavage of particular ncRNAs,
thereby defining new 5 ends to these transcripts. The miRNA-
defined 5 end sets the frame for processive cleavage of the
(presumably double-stranded) transcript at 21-nucleotide
intervals by the RNase Dicer, which generates multiple siRNA
molecules. At least some of these function as trans-acting
siRNAs that are complementary to, and mediate cleavage of,
mRNA targets different from those of the original miRNAs. The first miRNA discovered, lin-4 in  Caenorhabditis
elegans, was found by virtue of the severe cell-lineage defect
in mutant nematodes. Victor Ambros (Dartmouth College,
Hanover, USA), whose lab discovered the lin-4 RNA, contin-
ued the discussion of the biological roles of miRNAs by
describing several worm and fly miRNA knockouts. He sug-
gested that many animal miRNAs may work redundantly in
genetic circuits, as only the triple knockout of the let-7-
related miRNAs mir-48, mir-84 and mir-241 revealed a hete-
rochronic cell-lineage phenotype (in which the normal timing
of developmental events is perturbed). Ambros also described
how expression of mir-1 in mesodermal derivatives has been
conserved between invertebrates and vertebrates, and that
Drosophila lacking mir-1 display incredible defects in muscle
morphogenesis, such as alterations in myoblast fusion and
distortions in muscle morphology. Ronald Plasterk
(Hubrecht Laboratory, Utrecht, The Netherlands) described
the use of locked nucleic acid (LNA) probes to reveal beauti-
ful and diverse expression patterns of zebrafish miRNAs in
developing tissues and differentiated organs. This technique
has great potential to guide biological studies of miRNA func-
tion by indicating tissue-specific sites of regulation by indi-
vidual miRNAs. 
The genetics and mechanisms of RNAi
In the principal mechanism of gene silencing by RNAi, the
RNA-induced silencing complex (RISC) cleaves target
mRNAs that are complementary to the guide siRNA or
miRNA within RISC. Studies examining this key event in
greater detail were presented at the meeting, and the biogen-
esis of siRNAs/miRNAs and the steps that lead to the forma-
tion of RISC were also topics of great interest. New
approaches to identifying other factors with roles in the
RNAi pathway were also unveiled.
Although it has been known for some time that Dicer gener-
ates siRNAs and miRNAs, the lingering question of what
enzyme cleaves the mRNAs complementary to siRNAs and
miRNAs was answered only recently. Greg Hannon (Cold
Spring Harbor Laboratory, New York, USA) described
studies showing that recombinant human Argonaute 2
(hAgo2) is sufficient to cleave substrate RNA. Tuschl, John
Rossi (Beckman Research Institute of the City of Hope,
Duarte, USA), and Elisa Maniataki (University of Pennsylva-
nia, Philadelphia, USA) described many other factors that
co-purify with human RISC activity, including Dicer and
mammalian homologs of R2D2 and Armitage, proteins
known to be involved in RISC maturation in flies. The roles
of the novel proteins in RISC maturation and function are
under investigation. 
Hannon and Tuschl also reported that the 5 phosphate of
siRNAs is necessary for efficient siRNA incorporation into
native RISC; but this requirement can be bypassed when
highly purified hAgo2 is assayed instead. Hannon’s enzymatic
data suggest that the 5 phosphate may actually be the criti-
cal determinant of the specificity of substrate cleavage,
which occurs 10 base pairs from the 5 end of the siRNA.
Leemor Joshua-Tor (Cold Spring Harbor Laboratory) pre-
sented a structural tour of an archaeal Argonaute, where she
modeled the binding of an siRNA’s 5 phosphate by the Paz
domain and the expected location of catalytic residues in the
Argonaute Piwi domain near the tenth base pair of the
bound siRNA. 
The story of how RISC receives siRNAs continues to unfold,
with Phil Zamore (University of Massachusetts, Worcester,
USA) proposing that the asymmetric assembly of Dicer and
R2D2 on the siRNA duplex may be the initiation step for
asymmetric incorporation of single-stranded siRNAs into
RISC. He also described a more complicated assembly mech-
anism whereby Drosophila Ago2 cleaves the passenger
siRNA strand (the strand not incorporated into RISC) before
or during the unwinding of the siRNA duplex. Adding to this
discussion, Rossi noted that the minimal Dicer substrates of
27-nucleotide dsRNAs are more powerful drivers of siRNA-
RISC formation than the standard 21-nucleotide siRNAs,
suggesting that Dicer activity is directly coupled to RISC
assembly. The hunt is now on for an ‘unwindase’ enzyme
that separates the siRNA duplex into the single-stranded
siRNA incorporated into RISC. 
Studies of RISC assembly were complemented by the genetic
screens from Richard Carthew’s lab (Northwestern Univer-
sity, Evanston, USA), which had previously revealed the func-
tional partition of Dicer-1 and Dicer-2 in flies. Carthew
described new mutants that are deficient (‘RISC-free’) or
display enhanced (‘high-RISC’) RNAi activity, and discussed
how these are being used to define biochemical intermediates
of RISC assembly. In the quest to find more players in the
pathway, Gary Ruvkun (Harvard Medical School, Boston,
USA) and Craig Mello (University of Massachusetts) reported
the use of genome-wide RNAi and proteomics, respectively,
to identify novel factors involved in RNAi in C. elegans. These
include groups of Dicer-interacting proteins and chromatin-
regulating genes. Mello also touched upon a possible genetic
link between heritable forms of gene silencing triggered in
the germline by RNAi and the germ-cell-segregating P-
granule bodies in worms because mutations that disrupt P-
granule formation also appears to impair RNAi and
compromise siRNA accumulation.
Regulating chromatin by RNA
While RNAi is traditionally thought of as a cytoplasmic
phenomenon, small RNAs in protozoans, fungi, and plants
also function in the nucleus to induce modifications to his-
tones or DNA. This results in the packaging of DNA into
transcriptionally silent heterochromatin in plants and
fungi, and in the phenomenon of DNA elimination in pro-
tozoans. These RNA-based mechanisms are collectively
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ing how RNA feeds back to chromatin regulation may be
integral to the question of how cells can distinguish
euchromatin from silenced heterochromatin, which
includes centromeres and transposable elements. 
Shiv Grewal (National Cancer Institute, NIH, Bethesda,
USA) reviewed his groundbreaking work on the proteins
associated with the RNAi-based heterochromatic silencing of
the mating type (MAT) locus in the fission yeast Schizosac-
charomyces pombe, which contains centromeric repeats. He
proposed that the RNAi machinery acts in cis on the MAT
locus to induce transcriptional gene silencing and discussed
his recently published model of a complex, self-reinforcing
feedback pathway of heterochromatin regulation. Mohamed
Motamedi (Harvard Medical School) described the biochem-
ical dissection of the RNA-induced transcriptional silencing
(RITS) complex in S. pombe. Using a novel RNA-chromatin
immunoprecipitation technique, he concluded that RITS can
bind to the ‘aberrant’ RNAs that are transcribed from hete-
rochromatic loci. Robin Allshire (University of Edinburgh,
UK) proposed that S. pombe RNA polymerase II associates
with the RNAi machinery and is required for transcriptional
gene silencing, providing an additional layer of control to
heterochromatin regulation.
Progress reports on dissecting transcriptional gene silencing
in multicellular organisms began with the proposal from
Rob Martienssen (Cold Spring Harbor Laboratory) that
repeat elements in Arabidopsis, like centromeric repeats,
may need to be in tandem configuration in order to perpetu-
ate the self-reinforcing action of RNAi on heterochromatin.
Interestingly, Alan Herr (Sainsbury Laboratory, John Innes
Centre, Norwich, UK) described work showing that silenced
repeats and transposons in plants are specifically tran-
scribed by a novel RNA polymerase - possibly the recently
discovered polymerase IV. His results suggest that plants
employ a special polymerase distinct from the canonical
RNA polymerases I, II, and III for generating the type of
aberrant RNAs that ultimately feed into the chromatin-regu-
lation pathways that silence such loci. RNA polymerase IV
seems to be restricted to plants, but several other speakers
described intensive efforts to investigate the intersection of
RNAi and chromatin regulation in animals. For example,
David Looney (University of California at San Diego, USA)
and Kazunari Taira (University of Tokyo, Japan) suggested
that promoter-specific siRNAs can stimulate the formation
of silenced chromatin in human cells.
In addition to diminutive RNAs, large ncRNAs also regulate
transcription and gene expression in animals. For example,
the roX1 and roX2 RNAs are key components of a ribonucleo-
protein complex that upregulates gene expression on the
single X chromosome in male Drosophila to achieve gene-
dosage compensation. Mitzi Kuroda (Harvard Medical
School) reported that in Drosophila carrying both a mutation
of a nucleosome-remodeling protein and deletions of the
roX genes, a synthetic phenotype of chromosome defects is
now apparent. In contrast, there are no chromosome defects
when only the roX genes are deleted. This suggests that
there is an interplay between the roX RNAs and ATP-depen-
dent chromatin-remodeling machines. Mammalian dosage
compensation is controlled by the large ncRNA Xist, whose
expression is itself antagonized by transcription of the over-
lapping antisense ncRNA gene Tsix. Takashi Sado (National
Institute of Genetics, Shizuoka, Japan) and Claire Rougelle
(Institut Pasteur, Paris, France) reported the correlation of
Tsix expression with increased methylation of histone H3 at
the  Xist promoter, which probably suppresses Xist tran-
scription and hints at unsuspected links between these
ncRNAs and chromatin-modification processes. Renato Paro
(University of Heidelberg, Germany) illuminated the role of
transcribed ncRNAs in controlling the regulation of Poly-
comb/Trithorax-regulated enhancers in Drosophila. In
genes controlled by these enhancers, transcription of the
enhancer mediates an epigenetic switch from a Polycomb-
bound, repressed state to a Trithorax-bound, transcription-
ally active state.
Other classes of regulatory RNAs and their
functions
Of course, eukaryotes are not the only organisms that
possess ncRNAs; bacteria seem to have ncRNAs that are just
as rich in regulatory potential. Carin Vanderpool (National
Cancer Institute, NIH, Bethesda, USA) and Aixia Zhang
(National Institute of Child Health and Human Develop-
ment, NIH, Bethesda, USA) reported that several of the
more than 60 small regulatory RNAs in bacteria base-pair
with mRNAs to influence their transcription, stability, or
translational efficiency. Most of these targets are involved in
metabolic or stress pathways, and regulation by small RNAs
may allow rapid responses to a changing environment. Some
regulatory functions are actually embedded within mRNAs
themselves. Ron Breaker (Yale University, New Haven, USA)
reviewed his lab’s ongoing discovery of riboswitches, por-
tions of mRNA 5 UTRs which bind ligands that regulate the
stability or translation of the mRNA in an allosteric fashion.
Riboswitches are present in more than 2% of Bacillus sub-
tilis genes, particularly those involved in metabolite trans-
port or biosynthesis. Some riboswitches even appear to be
ribozymes that possess self-cleaving catalytic activity; an
example that extends the capabilities of regulatory RNAs
beyond simply target recognition.
A significant challenge for the study of ncRNAs still lies
simply in the identification of new entities. The discovery of
ncRNAs has historically been rather serendipitous; but their
unbiased, systematic identification in genomes may be possi-
ble in this post-genomic age. The remarkable extent of ‘non-
genic’ transcription was discussed by Tom Gingeras
(Affymetrix, Santa Clara, USA). Using tiling microarrays that
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Genome Biology 2005, 6:315systematically cover 10 human chromosomes at 5-nucleotide
resolution, his group has found that around 30% of the
human genome is transcribed at an experimentally detectable
level. Discrete, novel gene structures were then revealed by
large-scale hybridization of RACE (rapid amplification of
cDNA ends) reaction products to these microarrays. On the
computational side, Todd Lowe and Gill Bejerano (University
of California, Santa Cruz, USA) reported the identification of
a tremendous number of non-genic sequences in human,
mouse and rat that are under strong selective constraint, and
at least some of which may represent functional ncRNAs.
Lowe’s systemic search for ncRNAs is being conducted by fil-
tering hidden Markov model-based sequence alignments
through algorithms like QRNA, RNAfold, and SLAM to arrive
at promising candidate ncRNAs. Bejerano’s approach, on the
other hand, has been to examine large, ultraconserved ele-
ments of more than 200 base-pairs that are not exons and are
currently unannotated in vertebrate genomes. Bejerano has
been scanning these elements for their potential to form dis-
tinct RNA secondary structures, akin to those in rRNA genes,
which are also ultraconserved.
RNAi for functional discovery and therapeutics
RNAi has been widely applied to genome-wide forward
genetic analysis, both in traditional model organisms and in
vertebrates not previously amenable to genetic analysis.
Roderick Beijersbergen (Netherlands Cancer Institute, Ams-
terdam, The Netherlands) described 24,000 small hairpin
RNAs (shRNA) retroviral vectors targeting 8,000 human
genes, which have been used in several cancer-related
screens. Recently, his group has performed highly parallel
screens using a ‘barcode’ strategy in which experimental and
control cell populations are infected en masse with the entire
set of shRNAs. Following appropriate incubation and selec-
tion, they can quantify the overall distribution of shRNA
inserts using microarrays to identify ones that are signifi-
cantly over-represented.
Norbert Perrimon (Harvard Medical School, Boston, USA)
reviewed his lab’s systematic RNAi screens in Drosophila
using a library of 16,000 dsRNAs that are transfected into
various cultured cells. So far, they have performed about 50
genome-wide screens of cell biology, signal transduction and
host-pathogen interactions, including both quantitative
assays in plate-reader format and qualitative assays using
automated microscopy. He also described promising efforts
to miniaturize RNAi screening using microarrays.
Finally, progress towards unlocking the therapeutic potential
of RNAi was reported at the meeting. Yuriy Federov (Dhar-
macon, Lafayette, USA) discussed proprietary chemical mod-
ifications that appear to increase siRNA specificity and
decrease cytoxicity due to off-target effects. David Bumcrot
(Alnylam, Cambridge, USA) described how cholesterol levels
in mice could be lowered by simple intravenous delivery of
cholesterol-modified siRNAs that target the expression of
apolipoprotein B. Although clinical applications involving
RNAi are still years away, these efforts are providing the first
solid proof-of-principle that RNAi technologies may be
viable agents for gene therapy. 
Despite the incredible progress in recent years, key ques-
tions remain unanswered. How many other ncRNAs exist?
What are the endogenous functions of these novel ncRNAs,
including most miRNAs? What is the mechanism of miRNA-
mediated translational inhibition and transcriptional gene
silencing? And can the tantalizing therapeutic potential of
RNAi be realized in the near future? We look forward to
hearing about progress on these questions at a future Key-
stone Symposium.
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